The Vitamin D Therapy Market is expected to grow from USD 2.01 billion in 2019 to USD 4.52 billion by 2026 at a CAGR of 12.29% from 2019 to 2026.
Vitamins are a set of organic compounds that are fundamentals for the normal and healthy development of body. Vitamin D is a fat-soluble vitamin that is contemporary in very few foods. It is formed endogenously in the human body when ultraviolet rays from sunlight raid the skin and activate vitamin D synthesis. Vitamin D aids in the process of calcium absorption in the gut and maintains adequate calcium and phosphate attentions to allow normal mineralization of bone. Vitamin D deficiency primes to rickets, a disease in which the bone tissue doesn't properly mineralize, leading to soft bones and skeletal deformities. But gradually, research is revealing the importance of vitamin D in protecting against a host of health problems. increase in awareness about vitamin D deficiency, the surge in levels of malnutrition, rise in patient compliance to oral medications, increase in the frequency of hypovitaminosis D, aging population, sedentary lifestyles, and lack of exposure to the sun. The global market is segregated on the basis of Application as Muscle Weakness, Autoimmune Disorders, Other Applications, Osteoporosis, Rickets, and Skin Diseases. Based on Age Group the global market is segmented in Adults, Senior Adults, and Children. Based on Purchasing Pattern the global market is segmented in Prescription Drugs and OTC Drugs. Based on Route of Administration, the global market is segmented in Parenteral Route and Oral Route.
The global market report provides geographical analysis covering regions, such as Europe, North America, Asia Pacific, and the Rest of The World. The market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Sanofi, Torrent Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Cadila Healthcare Ltd, Novartis AG, Pfizer Inc, GlaxoSmithKline PLC, Merck & Co., Inc., Abbott, and others are among the major players in the global market. The companies studied in terms of product strategy and various n several growths and expansion strategies to gain a competitive edge in the market. The major players not only follow value chain integration with business operations in multiple stages of the value chain.
The global Vitamin D Therapy market has been segmented as below:
By Application
By Age Group
By Purchasing Pattern
By Route of Administration
By Region
By Company
The report covers the below scope:
The years considered for the study are as follows:
Report Scope:
The global market report scope includes a detailed study covering underlying factors influencing the industry trends. The report covers the analysis of regional and country-level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies. The report scope includes a detailed competitive outlook covering market shares and profiles key participants in the global market share. Major industry players with significant revenue share include Sanofi, Torrent Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Cadila Healthcare Ltd, Novartis AG, Pfizer Inc, GlaxoSmithKline PLC, Merck & Co., Inc., Abbott, and others.
Why Buy this Report:
Target Audience:
The report targeted the existing players in the industry is as follows:
Free and Paid Customization based on the requirement
Report Content
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter's Five Force Analysis
5.1 Introduction
5.2 Muscle Weakness
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Autoimmune Disorders
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Other Applications
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Osteoporosis
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Rickets
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Skin Diseases
5.7.1 Market Overview
5.7.2 Market Size and Forecast
6.1 Introduction
6.2 Adults
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Senior Adults
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Children
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7.1 Introduction
7.2 Prescription Drugs
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 OTC Drugs
7.3.1 Market Overview
7.3.2 Market Size and Forecast
8.1 Introduction
8.2 Parenteral Route
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Oral Route
8.3.1 Market Overview
8.3.2 Market Size and Forecast
9.1 Introduction
9.2 Europe
9.2.1 Europe Market, By Application
9.2.2 Europe Market, By Age Group
9.2.3 Europe Market, By Purchasing Pattern
9.2.4 Europe Market, By Route of Administration
9.3 North America
9.3.1 North America Market, By Application
9.3.2 North America Market, By Age Group
9.3.3 North America Market, By Purchasing Pattern
9.3.4 North America Market, By Route of Administration
9.4 Asia Pacific
9.4.1 Asia Pacific Market, By Application
9.4.2 Asia Pacific Market, By Age Group
9.4.3 Asia Pacific Market, By Purchasing Pattern
9.4.4 Asia Pacific Market, By Route of Administration
9.5 Rest of The World
9.5.1 Rest of The World Market, By Application
9.5.2 Rest of The World Market, By Age Group
9.5.3 Rest of The World Market, By Purchasing Pattern
9.5.4 Rest of The World Market, By Route of Administration
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
11.1 Sanofi
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 Torrent Pharmaceuticals Ltd.
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 Sun Pharmaceutical Industries Ltd.
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 Alkem Laboratories Ltd.
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Cadila Healthcare Ltd
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 Novartis AG
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 Pfizer Inc
11.7.1 Company Overview
11.7.2 Product/Service Landscape
11.7.3 Financial Overview
11.7.4 Recent Developments
11.8 GlaxoSmithKline PLC
11.8.1 Company Overview
11.8.2 Product/Service Landscape
11.8.3 Financial Overview
11.8.4 Recent Developments
11.9 Merck & Co., Inc.
&
By Application
By Age Group
By Purchasing Pattern
By Route of Administration